Cargando…
Altered Serum Phospholipids in Atopic Dermatitis and Association with Clinical Status
Circulating phospholipids have been considered as biomarkers and therapeutic targets in multiple disorders. Atopic dermatitis (AD) is the most common inflammatory skin disease. Although there are numerous studies having addressed stratum corneum lipids in the context of epidermal barrier, little is...
Autores principales: | Sakai, Takashi, Herrmann, Nadine, Maintz, Laura, Nümm, Tim Joachim, Welchowski, Thomas, Claus, Ralf A., Gräler, Markus H., Bieber, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844610/ https://www.ncbi.nlm.nih.gov/pubmed/35199091 http://dx.doi.org/10.1016/j.xjidi.2021.100092 |
Ejemplares similares
-
From Skin Barrier Dysfunction to Systemic Impact of Atopic Dermatitis: Implications for a Precision Approach in Dermocosmetics and Medicine
por: Maintz, Laura, et al.
Publicado: (2022) -
Barrier function and microbiotic dysbiosis in atopic dermatitis
por: Seite, Sophie, et al.
Publicado: (2015) -
Atopic dermatitis: an expanding therapeutic pipeline for a complex disease
por: Bieber, Thomas
Publicado: (2021) -
Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis
por: Bernardo, Diana, et al.
Publicado: (2023) -
Atopic dermatitis: a paradigmatic allergic skin disease.
por: Bieber, T
Publicado: (2001)